Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Cumberland Pharmaceuticals Releases Inaugural Report On Its Environmental, Social And Governance (ESG) Activities


 

April 28, 2020 - Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released its first Sustainability Report. This report describes the company's activities pertaining to Environmental, Social and Governance (ESG) matters, otherwise known as corporate sustainability. It includes details about Cumberland's community involvement, ethical marketing and drug safety.

Cumberland's board has appointed Caroline R. Young as the company's first ESG board director. She is the former president of the Nashville Health Care Council and founding executive director of Life Science Tennessee. Currently, Young is executive director of NashvilleHealth, an initiative focused on improving the health of citizens in the metropolitan Nashville, Tennessee area.

"As the largest biopharmaceutical company founded and headquartered in the mid-South, Cumberland is committed to sustainability and transparency," Young said. "This inaugural ESG report represents a milestone for Cumberland and will build upon the foundation of corporate responsibility the company has established over the years. We look forward to sharing updates as we fulfill this important initiative."

The sustainability reports notes that, during 2019, Cumberland provided nearly 4 million patient doses of its products, safely disposed of over 9,700 pounds of expired and damaged products and had no product recalls. The company also had no product listings on the FDA's Safety Alerts Database and no products identified in the FDA Adverse Event Reporting System during 2019.

"The ESG policies and practices we've built into our daily operations are central to our commitment to fulfilling our mission of delivering high-quality medicines, while addressing the interests of our shareholders, employees, partners and community," said A.J. Kazimi, chief executive officer of Cumberland Pharmaceuticals.

For more information on how Cumberland is addressing topics of importance to its employees, investors and the communities it serves, please view Cumberland's 2019 Sustainability Report at www.cumberlandpharma.com on the Corporate Governance section's Investor Relations page.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the delivery of high-quality prescription brands to improve patient care. The Company develops, acquires, and commercializes brands for the hospital acute care and gastroenterology market segments.

The Company's portfolio of FDA approved brands includes:

  • Acetadote® (acetylcysteine) Injection, for the treatment of acetaminophen poisoning;
  • Caldolor® (ibuprofen) Injection, for the treatment of pain and fever;
  • Kristalose® (lactulose) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation;
  • Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease;
  • Vaprisol® (conivaptan) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia;
  • Vibativ® (telavancin) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections;
  • RediTrex™ (methotrexate) Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis.

For more information on Cumberland's approved products, including full prescribing information, please visit the individual product websites, links to which can be found on the Company's website www.cumberlandpharma.com.

The Company also has a series of Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy ("DMD"), Systemic Sclerosis ("SSc"), and Aspirin-Exacerbated Respiratory Disease ("AERD"), Hepatorenal Syndrome ("HRS") and Portal Hypertension ("P.H.").

Forward-Looking Statements

This press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phases of Cumberland's operations are subject to factors outside of its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure, natural disasters, public health epidemics, and other events beyond our control, as more fully discussed in the Company's most recent Form 10-K and subsequent 10-Qs as filed with the SEC.

There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof.

Share:

 

Email Print

 

More Grand Rounds:

 

AMA Expands Online Education Hub to Further Streamline the Lifelong Learning, Licensure and Certification Needs of Physicians and Health Care Professi

AMA Expands Online Education Hub to Further Streamline the Lifelong Learning, Licensure and Certification Needs of Physicians and Health Care Professi

AMA Ed HubTM features new educational content from American Society of Addiction Medicine, Obesity Medicine Association, and the Society of Hospital Medicine and offers auto-reporting by American Board of Pathology to help physicians and health professionals improve care delivery

Read More

In light of the coronavirus pandemic, Meharry Medical College School of Dentistry graduates received academic achievement awards recognition in a creative way.

Read More

TriStar StoneCrest Debuts Scar-Free Transoral Thyroidectomy

The surgical team at TriStar StoneCrest Medical Center, under the direction of general surgeon, Joshua Taylor, MD, FACS, with The Surgical Clinic, has become the first in Tennessee to remove thyroid glands using an approach that leaves no visible scar. Rather than performing the surgery through an incision in the neck, which leaves a visible scar, this new scar-free minimally invasive approach was performed using very small incisions inside the mouth, between the gums and lower lip.

Read More

TJC Welcomes Mika Moser as COO

TJC Welcomes Mika Moser as COO

The Tennessee Justice Center recently Mika Moser as chief operating officer. Moser will manage operations at TJC, a nonprofit public interest law firm and advocacy center serving families throughout the state.

Read More

Wishes Granted

Wishes Granted

On June 16, two Vanderbilt University Medical Center physician scientists were each awarded a $220,000 grant to fund separate clinical research efforts to study diabetes. Only six fellows were selected nationally for the highly competitive grant competition to win 2020 Doris Duke Physician Scientist Fellowships ... and two hailed from VUMC.

Read More

HMP, SC&H Capital Enter Joint Venture

SC&H Capital, a leading investment banking and advisory firm has ntered into a joint venture with two healthcare consulting firms, Nashville-based Healthcare Management Partners (HMP) and Baltmore-based i3 Healthcare Consulting, to better serve the strategic and financial needs of the healthcare industry.

Read More

Martin Appointed EVP of Enterprise Technology for Change Healthcare

Martin Appointed EVP of Enterprise Technology for Change Healthcare

In late spring, Change Healthcare announced the appointment of Steven Martin as executive vice president of enterprise technology. Martin joined Change Healthcare from GE where he served as acting CEO for GE Digital. He previously spent over a decade at Microsoft where he was a key leader on their Azure cloud platform team.

Read More

PathGroup Selected as Early Access Partner for Launch of Illumina's Sequencing-Based COVID-19 Diagnostic Test

In June, Nashville-based PathGroup, one of the nation's largest private providers of pathology, clinical and molecular laboratory services, announced the company has been selected as an early access partner for the launch of Illumina's new sequencing-based COVID-19 test. COVIDSeq™ accommodates more than 3,000 test samples per run, allowing for a substantial increase in testing capacity.

Read More

American Airlines Taps into VUMC Expertise

Taking new actions that focus on the well-being and safety of customers and team members, American Airlines announced in late June that it has created a new Travel Health Advisory Panel that includes Vanderbilt University Medical Center (VUMC) infectious disease experts to advise on health and cleaning matters as travelers return over the summer.

Read More

TriStar Health Establishes Uninsured Assistance Hotline

TriStar Health Establishes Uninsured Assistance Hotline

TriStar Health and HCA Healthcare have established a health insurance coverage hotline to assist those whose insurance coverage has been impacted by a life-changing event, such as job loss or reduced income, as a result of the economic impact caused by COVID-19.

Read More

Ardent Health Services Selects American Red Cross Resuscitation Suite™ Program in Enterprise-wide Agreement with HealthStream

Innovative competency-based approach to resuscitation training at Ardent raises the bar on quality and empowers their workforce to improve patient outcomes

Read More

CET Life Sciences Center Welcomes Advansta As New Tenant

Cumberland Emerging Technologies, Inc. (CET) today announced that Advansta, a leading developer and supplier of protein characterization products, has established operations at the CET Life Sciences Center.

Read More

Study Finds Newborn Opioid Withdrawal Rates Show Evidence of Stabilizing

Read More

Heart Transplant Recipient to Bike 120 Miles for Multiple Sclerosis

Heart Transplant Recipient to Bike 120 Miles for Multiple Sclerosis

56-year-old Robert Marcom bikes 20 to 30 miles on a typical weekday morning. On weekends, 70-mile rides are pretty normal accomplishments for Robert.

Read More

Ascension Saint Thomas Proposes State's First Neighborhood Hospital

Ascension Saint Thomas Proposes State's First Neighborhood Hospital

Read More

Let's Give Them Something to Talk About!

Let's Give Them Something to Talk About!

Awards, Honors, Achievements

Read More

American College of Surgeons joins Surgical Care Coalition

Read More

Prevent Child Abuse Tennessee provides guidance for talking with children about race and anti-racism

Widespread protests in response to the murder of George Floyd by a Minneapolis police officer and countless other unjust killings of Black Americans throughout our country's history have brought the issues of racism and racial injustice to the forefront of family conversations.

Read More

Susan R. Bailey, M.D., inaugurated as 175th president of the AMA

Texas allergist becomes third consecutive woman to hold office

Read More

South Carolina Family Physician Chosen as AMA President-elect

The American Medical Association (AMA) today announced the election of Gerald E. Harmon, M.D., a family medicine physician from Pawleys Island, S.C., as the new president-elect of the nation's premier physician organization.

Read More

 
 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: